drugset
Drugs / Allogeneic neuroblastoma cells
last change Apr 2016 re-read 3 minutes ago

Allogeneic neuroblastoma cells

Cell therapy

Developed for
neuroblastoma
Investigated by
Baylor College of Medicine · Center for Cell and Gene Therapy, Baylor College of Medicine · St. Jude Children's Research Hospital · The Methodist Hospital Research Institute

Trials 1

today NCT01713439 · Ph 1
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01713439 Dec 1997 → Jan 2001 neuroblastoma Baylor College of Medicine Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Allogeneic neuroblastoma cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT01713439 ↗
Modality Cell therapy “Retrovirally transduced allogeneic neuroblastoma cell lines secreting the human interleukin-2 and lymphotactin genes” NCT01713439 ↗
Route Subcutaneous “The modified cancer cells will be injected under the patient's skin.” NCT01713439 ↗